Morana Vojnic, Director of Neuro-Oncology, Rutgers Cancer Institute, System Leader for Neuro-Oncology, Robert Wood Johnson Barnabas Health shared a post on LinkedIn:
“Excited to Present at TTLC 2026!
We’re thrilled to share our poster ‘Acquired NRG1 Fusion as a Mechanism of Secondary Resistance to EGFR Therapy in EGFR-Mutated Lung Cancer‘ presented by Juan Luis Gomez Marti.
Key insights include:
Examining how NRG1 fusions contribute to resistance in patients on EGFR TKIs.
Collaborative effort between institutions. Thank you to all the collaborators Marc Ladanyi, Sabina Hajiyeva, Marissa Mattar, Rachel Lai and Romel Somwar.
Grateful for the opportunity to share our findings!”
Other articles about TTLC on OncoDaily.